Stay updated on PRS-343 HER2+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.

Latest updates to the PRS-343 HER2+ Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe page footer revision was updated from **v3.5.2** to **v3.5.3**, reflecting a site release/version change rather than any change to the clinical trial’s content.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated to version 3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedUpdated the page revision to v3.5.0; the previous revision entry v3.4.3 was removed.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.2 was added, and the previous notices (including the funding-lapse notice and Revision: v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedAdded a site-wide notice about a lapse in government funding, stating that information may not be up to date and directing users to cc.nih.gov and opm.gov. Updated page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to PRS-343 HER2+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.